Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.

While it did not reach statistical significance, we also observed relatively large effects of PRS on disease progression among rare pathogenic variant carriers ( Figures S3 B and S3D).

also in 111,027 other papers